Identification of biological targets of therapeutic intervention for clear cell renal cell carcinoma based on bioinformatics approach

被引:12
|
作者
Chen, Yongsheng [2 ]
Teng, Lichen [2 ]
Liu, Wenhua [3 ]
Cao, Yan [2 ]
Ding, Dexin [2 ]
Wang, Wentao [2 ]
Chen, Hui [2 ]
Li, Changfu [2 ]
An, Ruihua [1 ]
机构
[1] Harbin Med Univ, Affiliated Hosp 1, Dept Urol, 31 Youzheng St, Harbin 150001, Province Heilon, Peoples R China
[2] Harbin Med Univ, Canc Hosp, Dept Urol, Harbin 150040, Heilongjiang, Peoples R China
[3] Harbin Med Univ, Affiliated Hosp 2, ICU Dept, Harbin 150086, Province Heilon, Peoples R China
关键词
Clear cell renal cell carcinoma; MicroRNAs; Differentially expressed genes; Protein-protein interaction; DEPENDENT REGULATION; GENE-EXPRESSION; KIDNEY CANCER; V COLLAGEN; NORMALIZATION; RNA; METABOLISM; MICRORNAS; MIGRATION; DIAGNOSIS;
D O I
10.1186/s12935-016-0291-8
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Background: We aimed to discover the potential microRNA (miRNA) targets and to explore the underlying molecular mechanisms of clear cell renal cell carcinoma (ccRCC). Methods: Microarray data of GSE16441 was downloaded from Gene Expression Omnibus database. Differentially expressed genes (DEGs) and differentially expressed miRNAs between ccRCC tumors and matched non-tumor samples were analyzed. Target genes of differentially expressed miRNAs were screened. Besides, functional enrichment analysis of DEGs was performed, followed by protein-protein interaction (PPI) network construction and sub-module analysis. Finally, the integrated miRNA-DEGs network was constructed. Results: A total of 1758 up- and 2465 down-regulated DEGs were identified. Moreover, 15 up- and 12 down-regulated differentially expressed miRNAs were screened. The up-regulated DEGs were significantly enriched in pathways such as cell adhesion molecules and focal adhesion. Besides, the down-regulated DEGs were enriched in oxidative phosphorylation, and citrate cycle (TCA cycle). Moreover, eight sub-modules of PPI network were obtained. Totally, eight down-regulated miRNAs were identified to significantly regulate the DEGs and miRNA-200c that could regulate collagen, type V, alpha 2 (COL5A2) as well as COL5A3 was found to be the most significant. Additionally, 10 up-regulated miRNAs were identified to be significantly associated with the DEGs. Thereinto, miRNA-15a that could regulate ATPase, H+ transporting, lysosomal 21 kDa, V0 subunit b (ATP6V0B) and miRNA-155 were found to be the most significant. Conclusions: miRNA-200c that could regulate COL5A2 and COL5A3, miRNA-15a that could regulate ATP6V0B and miRNA-155 may play key roles in ccRCC progression. These miRNAs may be potential targets for ccRCC treatment.
引用
收藏
页数:9
相关论文
共 50 条
  • [21] Therapeutic approaches in clear cell and non-clear cell renal cell carcinoma
    Vermassen, T.
    De Meulenaere, A.
    Van de Walle, M.
    Rottey, Sylvie
    ACTA CLINICA BELGICA, 2017, 72 (01) : 12 - 18
  • [22] MicroRNA Expression in Clear Cell Renal Cell Carcinoma Cell Lines and Tumor Biopsies: Potential Therapeutic Targets
    Swearson, Samuel
    Rataan, Aseel O.
    Eliason, Steven
    Amendt, Brad A.
    Zakharia, Yousef
    Salem, Aliasger K.
    Ho, Thai
    Rustum, Youcef M.
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2022, 23 (10)
  • [23] Construction of cuproptosis signature based on bioinformatics and experimental validation in clear cell renal cell carcinoma
    Tian, Xi
    Zhu, Shuxuan
    Liu, Wangrui
    Wu, Xinrui
    Wei, Gaomeng
    Zhang, Ji
    Anwaier, Aihetaimujiang
    Chen, Cong
    Ye, Shiqi
    Che, Xiangxian
    Xu, Wenhao
    Qu, Yuanyuan
    Zhang, Hailiang
    Ye, Dingwei
    JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, 2023, 149 (19) : 17451 - 17466
  • [24] Construction of cuproptosis signature based on bioinformatics and experimental validation in clear cell renal cell carcinoma
    Tian, X.
    Shuxuan, Z.
    Qu, Y.
    Hailiang, Z.
    Dingwei, Y.
    EUROPEAN UROLOGY, 2024, 85 : S1055 - S1055
  • [25] Construction of cuproptosis signature based on bioinformatics and experimental validation in clear cell renal cell carcinoma
    Xi Tian
    Shuxuan Zhu
    Wangrui Liu
    Xinrui Wu
    Gaomeng Wei
    Ji Zhang
    Aihetaimujiang Anwaier
    Cong chen
    Shiqi Ye
    Xiangxian Che
    Wenhao Xu
    Yuanyuan Qu
    Hailiang Zhang
    Dingwei Ye
    Journal of Cancer Research and Clinical Oncology, 2023, 149 : 17451 - 17466
  • [26] Antioxidants and Therapeutic Targets in Ovarian Clear Cell Carcinoma
    Amano, Tsukuru
    Murakami, Atsushi
    Murakami, Takashi
    Chano, Tokuhiro
    ANTIOXIDANTS, 2021, 10 (02) : 1 - 15
  • [27] Modeling clear cell renal cell carcinoma and therapeutic implications
    Wolf, Melissa M.
    Rathmell, W. Kimryn
    Beckermann, Kathryn E.
    ONCOGENE, 2020, 39 (17) : 3413 - 3426
  • [28] Modeling clear cell renal cell carcinoma and therapeutic implications
    Melissa M. Wolf
    W. Kimryn Rathmell
    Kathryn E. Beckermann
    Oncogene, 2020, 39 : 3413 - 3426
  • [29] Genome-wide gene expression profiles of clear cell renal cell carcinoma: Identification of molecular targets for treatment of renal cell carcinoma
    Hirota, Eiji
    Yan, Liang
    Tsunoda, Tatsuhiko
    Ashida, Shingo
    Fujime, Makoto
    Shuin, Taro
    Miki, Tsuneharu
    Nakamura, Yusuke
    Katagiri, Toyomasa
    INTERNATIONAL JOURNAL OF ONCOLOGY, 2006, 29 (04) : 799 - 827
  • [30] Orellanine specifically targets renal clear cell carcinoma
    Buvall, Lisa
    Hedman, Heidi
    Khramova, Alina
    Najar, Deman
    Bergwall, Lovisa
    Ebefors, Kerstin
    Sihlbom, Carina
    Lundstam, Sven
    Herrmann, Anders
    Wallentin, Hanna
    Roos, Emelie
    Nilsson, Ulf A.
    Johansson, Martin
    Tornell, Jan
    Haraldsson, Borje
    Nystrom, Jenny
    ONCOTARGET, 2017, 8 (53) : 91085 - 91098